SCHEMBL3488958

SCHEMBL3488958

COCCCOc1cc(OCc2ccccc2)cc(C(=O)O)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.75
KMT2A Q03164 2/20 0.75
NR4A2 P43354 3/20 0.58
KDM4E B2RXH2 1/20 0.56
NPC1 O15118 1/20 0.56
LMNA P02545 1/20 0.56
NR4A1 P22736 1/20 0.55
NR4A3 Q92570 1/20 0.55
GCK P35557 2/20 0.54
PLA2G2A P14555 1/20 0.52
MAOB P27338 2/20 0.52
SRD5A2 P31213 2/20 0.52
MRGPRX4 Q96LA9 2/20 0.52
NR1H4 Q96RI1 1/20 0.50
TP53 P04637 1/20 0.50
PKM P14618 1/20 0.50
NFKB1 P19838 1/20 0.50
RAB9A P51151 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1776182 0.97 MEN1 (0.75) MEN1KMT2ANR4A2KDM4ENPC1
SCHEMBL7597018 0.93 MEN1 (0.77) MEN1KMT2ANR4A2KDM4ENPC1
SCHEMBL9323885 0.90 MEN1 (0.82) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL3488635 0.89 MEN1 (0.58) MEN1KMT2ANR4A2KDM4ENPC1
SCHEMBL2808656 0.89 LMNA (0.59) MEN1KMT2ANR4A2KDM4ENPC1
SCHEMBL1426961 0.87 MEN1 (1.00) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL3487150 0.87 PLA2G2A (0.67) MEN1KMT2ANPC1PLA2G2ANR1H4
SCHEMBL2651146 0.86 KMT2A (0.79) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL340452 0.85 MEN1 (0.84) MEN1KMT2ANR4A2NPC1NR4A1
SCHEMBL29788233 0.85 MEN1 (0.84) MEN1KMT2ANR4A2NPC1NR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056497-A1 AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2010-03-04 US disclosed
US-20100056497-A1 AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2010-03-04 US disclosed
EP-2119702-A1 AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2009-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056497-A1 AMIDE DERIVATIVE REN, AGTR1, AGTR2 MEN1 825/4885KMT2A 921/4885NR4A2 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.